We are live on ! Find out more
ATXS

Astria Therapeutics

Delisted

ATXS was delisted on the 22nd of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$8.6M
RCM
2
RA Capital Management
Massachusetts
$8.47M
FFM
3
Fairmount Funds Management
Pennsylvania
$6.12M
VA
4
VR Adviser
New York
$3.62M
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.57M
Fidelity Investments
6
Fidelity Investments
Massachusetts
$2.38M +$2.11M +353,884 New
CAM
7
Cormorant Asset Management
Massachusetts
$2.01M -$1.51M -252,903 -46%
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$1.84M
Citadel Advisors
9
Citadel Advisors
Florida
$1.64M +$127K +21,392 +10%
IC
10
Ikarian Capital
Texas
$619K +$27.6K +4,643 +5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$524K +$78K +13,093 +20%
BCM
12
Bridgeway Capital Management
Texas
$431K +$115K +19,279 +43%
BlackRock
13
BlackRock
New York
$338K -$16K -2,687 -5%
AG
14
Artal Group
Luxembourg
$224K
AI
15
ArchPoint Investors
Florida
$173K
SB
16
Samsara BioCapital
California
$168K
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$166K -$79.8K -13,398 -35%
OC
18
Oppenheimer & Co
New York
$158K +$10.7K +1,800 +8%
Northern Trust
19
Northern Trust
Illinois
$135K -$11.4K -1,914 -9%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$124K +$110K +18,530 New
OQS
21
Occudo Quantitative Strategies
Florida
$103K -$691 -116 -0.8%
CC
22
Corton Capital
Ontario, Canada
$78K +$69.1K +11,597 New
Group One Trading
23
Group One Trading
Illinois
$77K +$54.4K +9,131 +397%
SSA
24
Schonfeld Strategic Advisors
New York
$77K +$68.5K +11,500 New
Morgan Stanley
25
Morgan Stanley
New York
$20K -$333 -56 -2%